Porton Pharma Solutions

    With over 3600 customer-centric employees, operations and commercial offices across the US, EU and China, Porton Pharma Solutions provides global pharmaceutical companies with innovative, reliable and end-to-end process R&D and manufacturing services across small molecule APIs, dosage forms and biologics.

    Our Process Technology Centers and WHO/USFDA/EMA/PDMA/NMPA-inspected Manufacturing Facilities feature state-of-the-art equipment, highly flexible cGMP-compliant production assets, plus over 500 highly skilled scientists and process engineers, all backed by a proven program management system dedicated to seamlessly delivering successful outcomes for your unique project requirements.

    RECENT ARTICLES

    DRUG DISCOVERY RESOURCES

    JOIN SUBSCRIBERS from

    • Johnson & Johnson
    • Roche
    • Pfizer
    • Novartis
    • Bayer
    • Merck
    • Sanofi
    • GlaxoSmithKline
    • AbbVie
    • Eli Lilly
    • Boehringer Ingelheim
    • Amgen
    • Bristol-Myers Squibb
    • Gilead
    • AstraZeneca
    • Teva
    • Novo Nordisk
    • Merck KGaA
    • Takeda
    • Celgene (BMS)
    • Biogen
    • Astellas
    • Daiichi Sankyo
    • Regeneron
    • UCB
    • Eisai
    • Servier
    • Kyowa Kirin
    • Shionogi
    • Vertex
    • Lundbeck
    • Taisho
    • Ono
    • Seagen
    • Incyte
    • LEO Pharma
    • Janssen
    • Galapagos
    • Idorsia
    • Astex
    • Arvinas
    • Kymera
    • Relay
    • Schrodinger
    • Mirati
    • Revolution
    • Nimbus
    • Plexxikon
    • Forma
    • Arcus
    • RA Capital
    • ARCH Venture Partners
    • MPM Capital
    • Orbimed
    • The Column Group
    • 5AM Ventures
    • Versant Ventures
    • Deerfield
    • Goldman Sachs
    • Citi
    • Piper Sandler
    • Softbank
    • …and hundreds of others